$2.69
Today
as of Sep 4, 16:53 ET
Last 30 days
Recent Press Releases & News
Quanterix (QTRX) Q2 2026 Earnings Call Transcript
Quanterix Reshapes Sales Strategy, Targets Q4 FDA Decision for Alzheimer’s Blood Test
Quanterix Insider Bought Shares Worth $286,354, According to a Recent SEC Filing
Overview
52-week range
$2.15
$8.77
8% of range
Avg surprise (last 3)
-5.8%
Avg reaction (last 2)
+4.1%
50% positive
Latest IV / EM
132%
EM ±21.3% · $3 · Sep 18
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue Jun 30, 2026 | Jun 2026 | $-1.04 | — | — | — | — | financials |
| Wed May 6, 2026 | Mar/2026 | $-0.39 | $-0.31 | -25.8% | +26.4% | -0.3% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $-0.73 | — | — | — | — | financials |
| Thu Aug 7, 2025 | Jun/2025 | $-0.47 | $-0.41 | -14.6% | — | — | earnings |
| Mon May 12, 2025 | Mar/2025 | $-0.53 | $-0.69 | +23.2% | — | +8.5% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-0.22 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-0.19 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-0.29 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-0.18 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-0.15 | — | — | — | — | financials |
| Thu Sep 30, 2021 | Sep 2021 | $-0.43 | — | — | — | — | financials |
| Wed Jun 30, 2021 | Jun 2021 | $-0.33 | — | — | — | — | financials |
| Wed Mar 31, 2021 | Mar 2021 | $-0.29 | — | — | — | — | financials |
Financials
Income statement (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $33M | $36M | — | $40M | $24M | $30M | — | $36M |
| Cost of revenue | $20M | $21M | — | $23M | $14M | $15M | — | $16M |
| Gross profit | $13M | $16M | — | $17M | $10M | $15M | — | $20M |
| Operating income | $-49M | $-41M | — | $-37M | $-37M | $-26M | — | $-12M |
| Net income | $-49M | $-18M | — | $-34M | $-30M | $-21M | — | $-8M |
| EPS (diluted) | $-1.04 | $-0.37 | — | $-0.73 | $-0.77 | $-0.53 | — | $-0.22 |
Balance sheet (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $44M | $36M | $30M | $38M | $133M | $77M | $57M | $29M |
| Inventory | $48M | $51M | $55M | $55M | $30M | $31M | $33M | $33M |
| Total current assets | $171M | $186M | $212M | $233M | $322M | $335M | $364M | $367M |
| Total assets | $320M | $367M | $419M | $444M | $376M | $397M | $407M | $411M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $82M | $85M | $123M | $130M | $83M | $80M | $76M | $72M |
| Total equity | $237M | $282M | $296M | $315M | $292M | $316M | $330M | $339M |